Statistics on Biotechnology Use Results by sector of operation Company sector. Biotechnology results by main variables and no. of employees. Unidades: specified in variables Fewer than 250 employees 250 or more employees Total No. of companies carrying out R&D in Biotechnology 1.040 93 1.133 %Companies according to biotechnology used: Genetic code 32 43 33 %Companies according to biotechnology used: Functional units 40 51 41 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 22 41 24 %Companies according to biotechnology used: Bioprocesses 48 69 50 %Companies according to biotechnology used: Sub-cellular organisms 5 12 6 %Companies according to biotechnology used: Bio-computing 24 28 24 %Companies according to biotechnology used: Nanobiotechnology 13 13 13 %Companies according to biotechnology used: Other 15 8 14 Companies in which biotechnology activities are: Main and/or exclusive 581 22 603 Companies in which biotechnology activities are: A secondary line of business 155 18 173 Companies in which biotechnology activities are: A tool necessary for production 305 53 357 %Company by field(s) of ultimate application of biotechnology use: Human Health 45 49 45 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 19 3 18 %Company by field(s) of ultimate application of biotechnology use: Food products 30 39 31 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 23 17 22 %Company by field(s) of ultimate application of biotechnology use: Environment 13 17 14 %Company by field(s) of ultimate application of biotechnology use: Industry 13 9 12 Personnel in R&D in biotechnology (no. of persons) 8.124 3.386 11.510 Personnel in R&D in biotechnology (no. of persons): Researchers 4.552 1.650 6.202 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 3.572 1.736 5.308 Personnel in R&D in biotechnology (no. of persons): women 4.363 2.026 6.389 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 2.368 935 3.304 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 1.995 1.090 3.086 Personnel in R&D in biotechnology (FTE) 5.788,1 2.448,9 8.236,9 Personnel in R&D in biotechnology (FTE): Researchers 3.364,3 1.231,9 4.596,1 Personnel in R&D in biotechnology (FTE): Technicians and assistants 2.423,8 1.217 3.640,8 Personnel in R&D in biotechnology (FTE): women 3.197,5 1.501 4.698,5 Personnel in R&D in biotechnology (FTE): (women) Researchers 1.803,7 708,8 2.512,5 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.393,8 792,2 2.186 Internal expenditure on R&D (thousands of euros) 558.184 211.247 769.431 1) By nature of the expense: Current expenses 518.032 201.684 719.715 1.1) Remuneration to researchers 154.555 66.892 221.447 1.2) Remuneration to technicians and assistants 72.617 50.192 122.809 1.3) Other current expenses 290.860 84.599 375.459 2) By nature of the expense: Capital expenses 40.152 9.563 49.715 2.1) Land and buildings 6.661 2.860 9.521 2.2) Equipment and instruments 24.465 6.001 30.466 2.3) Acquisition of specific R&D software 1.157 653 1.810 2.4) Otros productos de propiedad intelectual específicos para I+D 7.869 49 7.919 1.1) By origin of the funds: Own funds 385.847 105.066 490.913 1.2) By origin of the funds: From companies 53.140 29.409 82.548 1.3) By origin of the funds: Public Administration funds 64.168 32.641 96.809 1.4) By origin of the funds: From Universities 197 0 197 1.5) By origin of the funds: From non profit private institutions 588 4.177 4.766 1.6) By origin of the funds: Foreign funds 54.244 39.954 94.197 Purchase of R&D services in biotechnology (thousands of euros) 68.331 51.951 120.281 Purchase of R&D services in biotechnology (thousands of euros): In Spain 22.667 46.897 69.564 Purchase of R&D services in biotechnology (thousands of euros): Abroad 45.664 5.054 50.718 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 47 23 45 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 12 13 12 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 16 15 16 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 13 15 14 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 17 11 16 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 19 10 18 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 16 13 15 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 37 29 37 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 53 39 52 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 20 14 20 % Companies that have requested biotechnology patents in Biotechnology 15 17 15 Number of patents requested 525 156 681 % Companies with income of an international origin related to biotechnological activities 24,9 18,4 24,3 % Turnover representing income of an international origin related to biotechnological activities 6 1 1 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 45,2 73,1 59,6 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 54,8 26,9 40,4 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 89 72,5 80,4 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 7,5 24,9 16,5 % Income of an international origin related with activities according to the classification: Operating source abroad 2,2 2,3 2,2 % Income of an international origin related with activities according to the classification: Other 1,4 0,4 0,9 Notas: '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute